CDK9 and breast carcinoma: Another current intriguing exampleis the identification of parvinβ, a focal adhesion protein (lost in breast cancer patients), thatincreases the expression, S84 phosphorylation, and activity of PPARγ1 through cyclin-dependent kinase 9(CDK) and suppressed breast cancer growth in vivo [48].